Bryan Callen

Mr. Dunn looked at me and said, we wouldn't have it any other way. I had to go through an interview process. And through that process, the question was asked, what do we need to do with that money? And I said, well, let's recognize that while $842 million is a tremendous sum of money to the average ear, it's going to be paid to this state over 15 years.

Mr. Dunn looked at me and said, we wouldn't have it any other way. I had to go through an interview process. And through that process, the question was asked, what do we need to do with that money? And I said, well, let's recognize that while $842 million is a tremendous sum of money to the average ear, it's going to be paid to this state over 15 years.

Mr. Dunn looked at me and said, we wouldn't have it any other way. I had to go through an interview process. And through that process, the question was asked, what do we need to do with that money? And I said, well, let's recognize that while $842 million is a tremendous sum of money to the average ear, it's going to be paid to this state over 15 years.

At its height, Purdue Pharma was making $100 million a month off the sales of OxyContin. This settlement represents roughly eight and a half months of OxyContin sales, but we're going to be getting it over 15 years.

At its height, Purdue Pharma was making $100 million a month off the sales of OxyContin. This settlement represents roughly eight and a half months of OxyContin sales, but we're going to be getting it over 15 years.

At its height, Purdue Pharma was making $100 million a month off the sales of OxyContin. This settlement represents roughly eight and a half months of OxyContin sales, but we're going to be getting it over 15 years.

These are crumbs off the tables of gluttons, and we have got to make sure that this one-time non-recurring revenue stream is utilized for its maximum best impact to pull this state out of this travesty.

These are crumbs off the tables of gluttons, and we have got to make sure that this one-time non-recurring revenue stream is utilized for its maximum best impact to pull this state out of this travesty.

These are crumbs off the tables of gluttons, and we have got to make sure that this one-time non-recurring revenue stream is utilized for its maximum best impact to pull this state out of this travesty.

And I said, one thing that we have got to look for is an opportunity to develop a breakthrough therapeutic that can deliver materially better outcomes than what we are getting with our existing system. Our existing system is unacceptably mediocre, and it is necessary if we're going to change generational dynamics to improve upon what we have.

And I said, one thing that we have got to look for is an opportunity to develop a breakthrough therapeutic that can deliver materially better outcomes than what we are getting with our existing system. Our existing system is unacceptably mediocre, and it is necessary if we're going to change generational dynamics to improve upon what we have.

And I said, one thing that we have got to look for is an opportunity to develop a breakthrough therapeutic that can deliver materially better outcomes than what we are getting with our existing system. Our existing system is unacceptably mediocre, and it is necessary if we're going to change generational dynamics to improve upon what we have.

We've got to look for Kentucky's Manhattan Project opportunity to pioneer a therapeutic breakthrough for opioid addiction. And I said, I don't know what that is, but I'm going to get to looking. In 2018, I came into knowledge of the psilocybin mushroom.

We've got to look for Kentucky's Manhattan Project opportunity to pioneer a therapeutic breakthrough for opioid addiction. And I said, I don't know what that is, but I'm going to get to looking. In 2018, I came into knowledge of the psilocybin mushroom.

We've got to look for Kentucky's Manhattan Project opportunity to pioneer a therapeutic breakthrough for opioid addiction. And I said, I don't know what that is, but I'm going to get to looking. In 2018, I came into knowledge of the psilocybin mushroom.

and the way in which it has profound impacts on treatment-resistant anxiety and depression, and in the case of me in particular with my family's history, alcoholism. And I followed developments around its research applications over the next several years.

and the way in which it has profound impacts on treatment-resistant anxiety and depression, and in the case of me in particular with my family's history, alcoholism. And I followed developments around its research applications over the next several years.

and the way in which it has profound impacts on treatment-resistant anxiety and depression, and in the case of me in particular with my family's history, alcoholism. And I followed developments around its research applications over the next several years.

I came into contact with an author who goes by the pen name of Juliana Christina, who wrote beautifully about her own experiences with the psilocybin mushroom, which helped her overcome a lifetime of debility anchored in anxiety, depression, and a near fatal eating disorder. On July the 29th, 2022, I reached out to her and I said, hey. This is who I am. I've been given this job.

I came into contact with an author who goes by the pen name of Juliana Christina, who wrote beautifully about her own experiences with the psilocybin mushroom, which helped her overcome a lifetime of debility anchored in anxiety, depression, and a near fatal eating disorder. On July the 29th, 2022, I reached out to her and I said, hey. This is who I am. I've been given this job.